Trial ID
DR-01-ONC-001
Sponsor ID
Dren Bio
A Multicenter, Open-Label, First-in-Human, Multiple Expansion Cohort, Phase 1/2 Study to Evaluate the Safety and Efficacy of DR-01 in Adult Subjects with Large Granular Lymphocytic Leukemia or Cytotoxic Lymphomas
Principal Investigator
Alexander I. Spira, MD, PhD, FACPLocations
Fairfax Office
Learn More About This Trial
Other Relevant Trials
Trial ID
21552
Sponsor ID
RGX-104-001
“A Phase 1 Study of RGX-104, a Small Molecule LXR Agonist, as a Single Agent and as Combination Therapy in Patients with Advanced Solid Malignancies and Lymphoma with an Expansion in Select Malignancies (RGX-104-001)”
Principal Investigator
Alexander I. Spira, MD, PhD, FACP
Trial ID
2204+J+A243:I272
Sponsor ID
M23-362
A Phase 2, Open-Label Trial to Evaluate Safety of Epcoritamab monotherapy in Subjects with Relapsed or Refractory Diffuse Large B-cell Lymphoma and Follicular Lymphoma Grade 1-3a when Administered in the Outpatient Setting (M23-362)
